Huh, K.-Y.;                     Hwang, S.-j.;                     Park, S.-Y.;                     Lim, H.-J.;                     Jin, M.-y.;                     Oh, J.-s.;                     Yu, K.-S.;                     Chung, J.-Y.    
        Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib. Pharmaceutics 2021, 13, 629.
    https://doi.org/10.3390/pharmaceutics13050629
    AMA Style
    
                                Huh K-Y,                                 Hwang S-j,                                 Park S-Y,                                 Lim H-J,                                 Jin M-y,                                 Oh J-s,                                 Yu K-S,                                 Chung J-Y.        
                Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib. Pharmaceutics. 2021; 13(5):629.
        https://doi.org/10.3390/pharmaceutics13050629
    
    Chicago/Turabian Style
    
                                Huh, Ki-Young,                                 Se-jung Hwang,                                 Sang-Yeob Park,                                 Hye-Jung Lim,                                 Mir-yung Jin,                                 Jae-seong Oh,                                 Kyung-Sang Yu,                                 and Jae-Yong Chung.        
                2021. "Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib" Pharmaceutics 13, no. 5: 629.
        https://doi.org/10.3390/pharmaceutics13050629
    
    APA Style
    
                                Huh, K.-Y.,                                 Hwang, S.-j.,                                 Park, S.-Y.,                                 Lim, H.-J.,                                 Jin, M.-y.,                                 Oh, J.-s.,                                 Yu, K.-S.,                                 & Chung, J.-Y.        
        
        (2021). Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib. Pharmaceutics, 13(5), 629.
        https://doi.org/10.3390/pharmaceutics13050629